Vedrovin M 80mg/250mg Tablet
Marketer
Shreeji Healthcare Impex
Salt Composition
Drotaverine (80mg) + Mefenamic Acid (250mg)
Overview Vedrovin M 80mg/250mg Tablet
Abdominal pain relief is provided by the combined-ingredient tablet, GastroMend 80mg/250mg. This medication effectively alleviates abdominal pain, distension, discomfort, and spasms by inducing relaxation in the stomach and intestinal muscles. It simultaneously inhibits specific pain-inducing chemical signals. GastroMend 80mg/250mg should be ingested with meals, following your physician's prescribed dosage and regimen. Dosage is tailored to your individual needs and response. Continue the prescribed course of treatment; premature discontinuation may lead to symptom recurrence and condition exacerbation. Inform your healthcare provider of all other medications you are using, as interactions are possible. Common side effects include nausea, vomiting, diarrhea, abdominal pain, dry mouth, anorexia, thirst, and heartburn. These are generally transient and self-limiting. Report any concerning side effects to your doctor immediately. Dizziness and somnolence may occur; avoid driving or activities demanding concentration until the medication's effects are known. Alcohol consumption should be avoided due to potential increased dizziness. Before commencing treatment, disclose any pregnancy, pregnancy planning, breastfeeding, kidney disease, or liver disease to your physician for appropriate dose adjustment.
Primary Ingredients of Vedrovin M 80mg/250mg Tablet
No information provided. Please provide the text you wish to be rewritten.
Uses of Vedrovin M 80mg/250mg Tablet
Managing abdominal discomfort
Major Benefits of Vedrovin M 80mg/250mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the 80mg/250mg Vedrovin M Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
Common Side effects of Vedrovin M 80mg/250mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Dryness in mouth
- Heartburn
- Vertigo
- Insomnia (difficulty in sleeping)
- Hypotension (low blood pressure)
- Fast heart rate
- Sweating
- Constipation
- Increased liver enzymes
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Purpura
- Agranulocytosis (deficiency of granulocytes in the blood)
- Breathlessness
- Ringing in ear
- Abdominal pain
- Flatulence
- Indigestion
- Stomach inflammation
- Confusion
- Depression
How to use Vedrovin M 80mg/250mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and timeframe. Ingest the 80mg/250mg Vedrovin M Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
How Vedrovin M 80mg/250mg Tablet works:
Each Vedrovin M 80mg/250mg tablet combines drotaverine and mefenamic acid to alleviate abdominal pain and cramping. Drotaverine, an antispasmodic, targets and reduces smooth muscle contractions in the abdomen. Mefenamic acid, a nonsteroidal anti-inflammatory drug (NSAID), inhibits the production of inflammatory chemicals responsible for abdominal pain and swelling.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol and Vedrovin M 80mg/250mg Tablet ingestion is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Vedrovin M 80mg/250mg Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against these risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
Data on the safety of Vedrovin M 80mg/250mg Tablet while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by Vedrovin M 80mg/250mg Tablets, a potential side effect of the medication due to the risk of dizziness.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Vedrovin M 80mg/250mg tablets, potentially requiring dosage modification. Medical advice is essential. The use of Vedrovin M 80mg/250mg tablets is contraindicated in individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Vedrovin M 80mg/250mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised.
What if you forget to take Vedrovin M 80mg/250mg Tablet :
Should you forget a Vedrovin M 80mg/250mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vedrovin M 80mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
3,018 People bought this recently